Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks

NCT05598814 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis with Nasal Polyps
Asthma

Interventions

BIOLOGICAL: Mepolizumab Injection
PROCEDURE: Functional Endoscopic Sinus Surgery (FESS).

Sponsor

Vibeke Backer